Press Releases
Your resource for the latest Grifols news. You can search all published press releases by year and news category, or by using the search bar below.
Showing 188 search results
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2023
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
Grifols shareholders approve all agenda items at 2024 Annual General Meeting
Grifols succesfully closes the issuance of additional EUR 300 million secured notes
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors
Grifols on track to meet full-year guidance and reduce debt
Grifols on track to close its strategic alliance with Haier in first half 2024
Grifols successfully completes its EUR 1 billion private placement of senior secured notes
Grifols launches its Erytra Eflexis, a powerful blood-typing system, in China
Grifols announces signing of private offering of EUR 1 billion senior secured notes due 2030